Abstract PD13-02: Phase Ib expansion study of gedatolisib in combination with palbociclib and endocrine therapy in women with ER+ metastatic breast cancer
Year: 2022
Type: conference-abstract
Source: Cancer Research
Institutions: The University of Texas MD Anderson Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Moffitt Cancer Center, University of Washington, Fred Hutch Cancer Center, Cancer Consortium, University of Alabama at Birmingham, UNC Lineberger Comprehensive Cancer Center, University of Colorado Hospital, University of Colorado Anschutz, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, The Barbara Ann Karmanos Cancer Institute, USC Norris Comprehensive Cancer Center, Emory University Hospital, Harvard University, Massachusetts General Hospital, University of Michigan, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4220710795